Dimethylamine

Dimethylamine

SCHEMBL4121108

CNC.Cc1c(-c2ccccn2)ccc2c(CCC3CCN(C(=O)O)CC3)noc12

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACHE P22303 18/20 0.41
BCHE P06276 3/20 0.41
SCD5 Q86SK9 1/20 0.36
NAMPT P43490 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL4122103 0.89 GPR119 (0.42) ACHEBCHE
Dimethylamine SCHEMBL4121165 0.88 ACHE (0.44) ACHEBCHE
SCHEMBL4125005 0.86 ACHE (0.41) ACHEBCHESCD5
SCHEMBL4121102 0.85 ACHE (0.40) ACHEBCHESCD5
Dimethylamine SCHEMBL4126431 0.85 ACHE (0.39) ACHEBCHE
Dimethylamine SCHEMBL4128004 0.84 ACHE (0.40) ACHEBCHESCD5NAMPT
Dimethylamine SCHEMBL4418002 0.84 ACHE (0.47) ACHEBCHE
Dimethylamine SCHEMBL4122976 0.83 ACHE (0.40) ACHEBCHESCD5
Dimethylamine SCHEMBL4127351 0.83 ACHE (0.44) ACHEBCHE
Dimethylamine SCHEMBL4124797 0.83 ACHE (0.40) ACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
EP-2017275-A1 BENZISOXAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2009-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318690-A1 Benzisoxazole Compound NR1I2, NR1I3, NR0B1 ACHE 3716/4885BCHE 2215/4885SCD5 3576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.